Family · Pharmaceutical analytical standards
Clascoterone
A topical steroidal antiandrogen, cortexolone 17-alpha-propionate, that blocks the androgen receptor directly in the skin: approved in the United States in 2020 as a cream for acne, the first of its class, and authorised in the European Union in 2025. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It has also been studied on the scalp for androgenetic hair loss: in two phase III trials, disclosed at the end of 2025, it grew more hair than placebo.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
